Intermediate for Efinaconazole. Efinaconazole (trade names: Jublia and Clenafin) is a 14α-demethylase inhibitor for the treatment of onychomycosis (fungal infection of the nail). Efinaconazole has been approved by the U.S Food and Drug Administration on June 6, 2014.
Product Name: 1-(((2R,3S)-2-(2,4-Difluorophenyl)-3-methyloxiran-2-yl)methyl)-1H-1,2,4-triazole
CAS Number: 127000-90-2
Molecular Weight:  251.2352
Molecular Formula:  C12H11F2N3O
Purity (HPLC): ≥95%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.